期刊文献+

百令胶囊辅助治疗早期糖尿病肾病临床观察 被引量:6

Clinical Studies of Adjuvant Therapeutic Effects of Bailing Capsule on the Treatment of Early Diabetic Nephropathy
原文传递
导出
摘要 目的:观察百令胶囊辅助治疗早期糖尿病肾病的疗效。方法:90例早期糖尿病肾病患者随机分为治疗组与对照组各45例,两组患者在良好控制血糖、血压基础上,治疗组加用百令胶囊1g,po tid,疗程12周;治疗前后监测空腹血糖(FBG)、24 h尿微量白蛋白(UMA)定量、C反应蛋白(CRP)、尿素氮(BUN)、血肌酐(SCr)、血清总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)。结果:治疗组治疗后CRP、24 h UMA明显下降,与对照组比较差异有统计学意义(P<0.01)。TC、TG、LDL明显下降,与对照组比较差异有统计学意义(P<0.05)。两组疗效亦有明显差异(P<0.05)。结论:百令胶囊能够明显减少24 h UMA、CRP、TC、TG和LDL,对早期糖尿病肾病有良好的辅助治疗作用。 Objective:To observe the therapeutic effects of bailing capsule on the treatment of patients with early diabetic nephropathy(DN), nethod:A comparative synchronous study was conducted between 45 early DN patients treated with bailing capsule( 1.0 g, po tid) for 12 weeks (treated group)and the other 45 early DN patients treated without bailing capsule (controlled group), based on the routine therapy and the well controlled FBG and 24 h UMA, CRP, BUN, SCr, TC, TG, HDL, LDL were tested during the treatment. Result :24h UMA and CRP in the treated group were reduced more significantly( P 〈 0.01 ) than in the controlled group. TC, TG and LDL were reduced significantly( P 〈 0.05 ). Conclusion: Bailing capsule could significantly reduce the 24 h UMA, CRP,TC ,TG and LDL, and had its good therapeutic effects on early diabetic nephropathy.
作者 罗方 胡江平
出处 《药物流行病学杂志》 CAS 2011年第7期334-336,共3页 Chinese Journal of Pharmacoepidemiology
关键词 糖尿病肾病 百令胶囊 微量白蛋白尿 C反应蛋白 Early diabetic nephropathy Bailing Capsule 24 h UMA CRP
  • 相关文献

参考文献5

  • 1Romano M, Pomilio M, Vignefi S, et al. Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflanmatory reaction [ J ]. Diabetes Care, 2001 , 24 ( 9 ) : 1674 -1675.
  • 2Zweiker R. Stoschitzky K. Maier R. Efficiency and safety of ACE-inhibiting imidapril in patients with essential hypertension [ J ]. Acta Medica A ustriaca., 2002,29 ( 2 ) :72-76.
  • 3Barzilay JI, Abraham L, Heekbert SR,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Stlidy [ J ]. Diabetes,2005 ,50(10) :2384-2389.
  • 4王虹,李文英,胡晓梅.老年2型糖尿病患者应用罗格列酮治疗前后血清C反应蛋白的改变[J].解放军保健医学杂志,2007,9(2):85-87. 被引量:4
  • 5赵继红.百令胶囊对慢性肾功能不全患者脂代谢水平的影响[J].天津中医,2002,19(5):9-9. 被引量:7

二级参考文献8

  • 1[1]Ablij H,Meinders A.C-reactive protein:history and revival[J].Eur J Intern Med,2002,13:412.
  • 2[2]Martens FM,Visseren FL,Lemay J,et al.Metabolic and additional vascular effects of thiazolidinediones[J].Drugs,2002,62:1463-1480.
  • 3[3]Eekel RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365:1415-1428.
  • 4[4]Dandona P,Aljada A.Dhindsa S,et al.Insulin as an anti-inflammatory and antiatherosclerotic hormone[J].Clin Cornerstone,2003,(Suppl 4):S13-S20.
  • 5[5]Ladwig K,Marten-Mittag B,Lowel H,et al.Influence of depressive mood on the association of CRP and obesity in 3205 middie aged healthy men[J].Brain Behav Immun,2003,17:268-275.
  • 6[6]Chilcott J,Tappenden P,Jones ML,et al.A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus[J].Clin Ther,2001,23:1792-1823.
  • 7[7]van Oostrom AJ,van Wijk J,Cabezas MC.Lipaemia,inflammation and atherosclerosis:novel opportunities in the understanding and treatment of atherosclerosis[J].Drugs,2004,64(Suppl 2):19-41.
  • 8[8]Yang L,An HX,Deng XL,et al.Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2associated phosphatidylinositol 3-kinase pathway[J].Acta Pharmacol Sin,2003,24:429-434.

共引文献9

同被引文献168

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部